Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

JAN

JanOne Inc

May 13 • 04:00PM ET

3.84

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF BSVO CCSO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.23	Insider Own	11.05%	Shs Outstand	9.06M	Perf Week	-7.02%
Market Cap	34.79M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	8.06M	Perf Month	30.17%
Income	-16.46M	PEG	-	EPS next Q	-	Inst Own	2.54%	Short Float	2.22%	Perf Quarter	476.49%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-7.54%	Short Ratio	0.64	Perf Half Y	623.16%
Book/sh	-0.56	P/B	-	EPS next Y	-	ROA	-69.38%	Short Interest	0.18M	Perf Year	265.71%
Cash/sh	0.01	P/C	579.84	EPS next 5Y	-	ROE	-104.08%	52W Range	0.22 - 5.26	Perf YTD	591.89%
Dividend Est.	-	P/FCF	-	EPS past 5Y	23.21%	ROI	-165.65%	52W High	-27.00%	Beta	2.15
Dividend TTM	-	Quick Ratio	0.15	Sales past 5Y	-17.99%	Gross Margin	17.19%	52W Low	1642.29%	ATR (14)	0.60
Dividend Ex-Date	-	Current Ratio	0.15	EPS Y/Y TTM	41.00%	Oper. Margin	0.00%	RSI (14)	51.93	Volatility	14.36% 19.87%
Employees	5	Debt/Eq	0.38	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.30	EPS Q/Q	80.97%	Payout	-	Rel Volume	0.00	Prev Close	3.84
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	278.12K	Price	3.84
SMA20	-6.42%	SMA50	19.07%	SMA200	211.63%	Trades		Volume	0	Change	0.00%

May-13-24 07:30AM	JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider (PR Newswire)
07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
May-10-24 04:10PM	JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider (PR Newswire)
May-03-24 10:52PM	JAN Stock Earnings: JanOne Reported Results for Q1 2024 (InvestorPlace)
Mar-15-24 09:00AM	JanOne Regains Compliance with Nasdaq's Listing Requirements (PR Newswire)
08:05AM	Loading…
Nov-09-23 08:05AM	Why Is JanOne (JAN) Stock Up 40% Today? (InvestorPlace) +64.75%
Sep-21-23 11:30AM	JanOne to Present at the Dawson James 8th Annual Investment Conference (PR Newswire)
09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Aug-31-23 01:30PM	JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference (PR Newswire) -23.58%
Aug-29-23 01:30PM	JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain (PR Newswire)
Aug-25-23 02:30PM	JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting (PR Newswire)
Aug-22-23 05:30PM	JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire) -6.31%
Aug-18-23 07:00PM	JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire) +5.64%
12:42PM	JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting (PR Newswire)
Jun-28-23 08:30AM	JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain (PR Newswire)
08:30AM	Loading…
Apr-18-23 08:30AM	JanOne Completes Pre-IND Meeting with FDA on Jan123 (PR Newswire) -7.48%
Apr-13-23 08:30AM	JanOne to Present Data On Its Two Non-Opioid Drug Candidates at The Appalachian Region Spine and Pain Meeting on Drug Development Programs to Treat Pain on April 15, 2023 (PR Newswire)
Mar-24-23 10:55AM	JanOne Technologies Announces Closing of Registered Direct Offering of Common Stock Priced At-The-Market (PR Newswire) +7.20%
Mar-23-23 08:30AM	JanOne Welcomes John Bonfiglio -- Veteran Biotech Executive, Deal Maker and Strategist -- to Top Management Team (PR Newswire)
08:00AM	JanOne Technologies Announces Registered Direct Offering of Common Stock Priced At-The-Market (PR Newswire)
Mar-22-23 08:30AM	JanOne Sells Legacy Business ARCA Recycling to Concentrate on Growing BioPharm Businesses (PR Newswire) +9.40%
Feb-22-23 08:30AM	JanOne to Present Important Trial Results at Annual Meeting of American Society of Interventional Pain Physicians (PR Newswire)
Jan-26-23 08:30AM	JanOne Charts Ambitious Strategic Course for Non-Addictive Pain Management (PR Newswire)
Jan-10-23 08:30AM	JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC (PR Newswire) +7.53%
Sep-16-22 09:46AM	National drug development firm acquires innovative Dayton company (American City Business Journals)
09:30AM	JanOne Inc. Executes Term Sheet to Acquire Soin Therapeutics LLC (PR Newswire)
Jul-05-22 09:00AM	ARCA Recycling, a Subsidiary of JanOne Inc., Unveils New Logo and Website (PR Newswire)
Jun-28-22 09:00AM	JanOne Inc. Announces an Improved Formulation of JAN101 (PR Newswire) -7.02%
Jun-09-22 08:30AM	ARCA Recycling, Inc., a Subsidiary of JanOne Inc., Opens Three New Recycling Centers in Washington, California and New Jersey (PR Newswire)
Jun-08-22 07:07AM	Emerging Markets Report: Right on Traq (GlobeNewswire) -7.13%
08:30AM	Loading…
Jun-07-22 08:30AM	JanOne Inc. Announces the Issuance of U.S. Patent Covering a Method of Improving Nerve Function Using JAN101 (PR Newswire) +62.80%
May-31-22 09:00AM	SPYR Technologies Enters into Material Definitive Agreement to Acquire GeoTraq, Inc. (GlobeNewswire) +66.52%
08:30AM	JanOne Sells GeoTraq to SPYR Technologies in a $13.5 Million Transaction (PR Newswire)
Apr-07-22 06:31PM	An Intrinsic Calculation For Janison Education Group Limited (ASX:JAN) Suggests It's 28% Undervalued (Simply Wall St.)
Jan-25-22 09:38AM	Price Capital Management, Inc. Buys JanOne Inc, Sells iShares U.S. ... (GuruFocus.com) +5.67%
Jan-21-22 09:38PM	ATP Life Science Ventures, L.P. Buys JanOne Inc (GuruFocus.com) -10.36%
Jan-04-22 09:00AM	JanOne Inc. Develops Plan for Treating Methamphetamine Use Disorder (PR Newswire) -5.97%
Dec-16-21 09:00AM	ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contract in Virginia and North Carolina With Total Estimated Value of $1.6 Million for Work through 2023 (PR Newswire) -5.39%
Dec-07-21 09:00AM	JanOne Inc. Acquires an Option for the Rights to a Worldwide, Exclusive License for a Novel Strategy for Treating Methamphetamine Use Disorder (PR Newswire) +7.93%
Nov-08-21 06:58AM	Is JanOne (NASDAQ:JAN) Using Debt In A Risky Way? (Simply Wall St.)
Oct-27-21 09:00AM	ARCA Recycling, a Subsidiary of JanOne Inc., Launches Two Recycling Programs in California in Effort to Reduce GHG Emissions (PR Newswire)
Oct-19-21 09:00AM	ARCA Recycling, a Subsidiary of JanOne Inc., Sees Major Increase in Appliance Replacement Contracts, Estimated to Push Revenue of Replacement Programs to Nearly $20 Million, in Addition to Recycling Business (PR Newswire)
Oct-12-21 09:00AM	ARCA Recycling, a Subsidiary of JanOne Inc., Opens Recycling Center in Michigan to Support New Multi-Year Contracts Totaling Millions in Revenue (PR Newswire)
Oct-07-21 09:00AM	ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contracts in Pennsylvania With Total Estimated Value of 20 Million Dollars for Work in the State to Continue Through 2026 (PR Newswire)
Sep-30-21 09:00AM	ARCA Recycling, a Subsidiary of JanOne Inc., Opens New Pennsauken, NJ, Recycling Center, Launches New Recycling Programs (PR Newswire) -5.52%
Sep-28-21 04:05PM	JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101 (PR Newswire) +7.54%
Jul-22-21 09:45AM	JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients (PR Newswire)
Jun-23-21 10:10AM	JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites (PR Newswire) -5.48%
Jun-22-21 09:46AM	JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing (PR Newswire) +10.31%
Jun-15-21 10:15AM	JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board (PR Newswire)
Jun-10-21 10:15AM	JanOne Engages DC Consulting LLC for Government and Private Sector Initiatives (PR Newswire) +5.73%
Jun-08-21 09:45AM	JanOne Advances Toward Initiation of Phase 2b Peripheral Artery Disease (PAD) Trial for Lead Product Candidate JAN101 (PR Newswire) +10.80%
Feb-25-21 09:29AM	JanOne Announces Definitive Agreement to Sell its Legacy Recycling Business for $25 Million (PR Newswire) +16.49%
Feb-02-21 11:45AM	JanOne Announces Closing of $6.0 Million Common Stock Offering (PR Newswire) +7.45%
Jan-29-21 08:45AM	JanOne Prices $6.0 Million Common Stock Offering (PR Newswire) -30.64%
Sep-24-20 10:45AM	JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study (PR Newswire)
Sep-22-20 09:45AM	JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent Pharma Asset Potential for Peripheral Artery Disease (PR Newswire) +5.06%
Sep-16-20 02:37PM	JanOne Announces Strategic Plan to Divest its Legacy Businesses (PR Newswire)
Sep-03-20 10:30AM	JanOne confirms stability data of JAN101 development batch and prepares for commercial GMP production to support the upcoming PAD and potential Covid-19 clinical trials (PR Newswire) -5.66%
Aug-31-20 05:00PM	LD Micro - 360 Companies - Set to Present this Week (ACCESSWIRE) -10.40%
Aug-28-20 02:34PM	JanOne Selects Partner for Bottling and Labeling of JAN101 for Peripheral Artery Disease and Potential Covid-19 Clinical Trials (PR Newswire)
Aug-26-20 09:45AM	JanOne Advances its Potential Peripheral Artery Disease and Covid-19 Vascular Inflammation Treatment Towards Trial Readiness (PR Newswire)
Aug-21-20 10:31AM	JanOne to Host Telebriefing to Discuss Drug Candidate JAN101 for Treatment of Peripheral Artery Disease (PAD) and Potential Applications for COVID-19 Vascular Complications (PR Newswire) +14.04%
Aug-19-20 02:50PM	JanOne to Present at The LD 500 Virtual Conference (PR Newswire) +15.81%
Aug-11-20 07:00PM	/C O R R E C T I O N -- JanOne/ (PR Newswire)
Aug-06-20 02:30PM	JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications (PR Newswire) +35.43%
Aug-04-20 09:47AM	JanOne Changes Internal Drug Candidate Name from TV1001SR to JAN101 (PR Newswire)
Jul-30-20 09:30AM	JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain (PR Newswire)
Jul-21-20 09:25AM	JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets (PR Newswire)
Jul-08-20 09:30AM	Dr. Rakesh Patel, internationally recognized scientist in nitric oxide and redox biology, and Dr. Timothy Ness, a pain mechanisms and medication expert, join JanOne's Scientific Advisory Board (PR Newswire) +5.83%
Jun-30-20 09:30AM	One of the nation's most renowned pain experts, Dr. Edgar Ross, joins JanOne's Scientific Advisory Board (PR Newswire) +6.84%
Jun-25-20 02:23PM	JanOne taps distinguished chemist Dr. Doug Flanagan as chief formulation advisor (PR Newswire)
Jun-18-20 09:27AM	JanOne Launches Strategic Alternatives Process for Legacy Businesses (PR Newswire) -7.80%
Feb-06-20 09:02AM	JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development (PR Newswire) +31.63%
Jan-28-20 09:02AM	Amol Soin, MD, One Of The Nation's Leading Pain Experts, Named As JanOne's Chief Medical Officer (PR Newswire)
Jan-23-20 09:02AM	JanOne Scientific Advisory Board Chair and Leading Pain Expert Featured on ABC-7 WJLA America This Week (PR Newswire)
Jan-16-20 10:51AM	Leading Cardiovascular Researcher And PAD Treatment Pioneer, Dr. Christopher Kevil, To Chair JanOne Scientific Advisory Board (PR Newswire) +22.88%
Dec-03-19 09:03AM	JanOne Names Tony Giordano, Ph.D., as Chief Scientific Officer (PR Newswire) -11.58%
Nov-25-19 09:00AM	JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD) (PR Newswire) +54.51%
Sep-12-19 08:00AM	JanOne Names America This Week Host And Financial Commentator Eric Bolling As President And Chairman (PR Newswire) -9.37%
Sep-11-19 08:03AM	ARCA Now Doing Business as JanOne, Trades Under New Nasdaq Ticker Symbol JAN (PR Newswire) +7.49%

JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JAN

JanOne Inc

Upgrade your FINVIZ experience